Objective: The objective of our study was to compare dose-length product (DLP)-based estimates of effective dose with organ dose-based calculations using tissue-weighting factors from publication 103 of the International Commission on Radiological Protection (ICRP) or dual-energy CT protocols.
Materials and methods: Using scanner- and energy-dependent organ dose coefficients, we calculated effective doses for CT examinations of the head, chest, coronary arteries, liver, and abdomen and pelvis using routine clinical single- or dual-energy protocols and tissue-weighting factors published in 1991 in ICRP publication 60 and in 2007 in ICRP publication 103. Effective doses were also generated from the respective DLPs using published conversion coefficients that depend only on body region. For each examination type, the same volume CT dose index was used for single- and dual-energy scans.
Results: Effective doses calculated for CT examinations using organ dose estimates and ICRP 103 tissue-weighting factors differed relative to ICRP 60 values by -39% (-0.5 mSv, head), 14% (1 mSv, chest), 36% (4 mSv, coronary artery), 4% (0.6 mSv, liver), and -7% (-1 mSv, abdomen and pelvis). DLP-based estimates of effective dose, which were derived using ICRP 60-based conversion coefficients, were less than organ dose-based estimates for ICRP 60 by 4% (head), 23% (chest), 37% (coronary artery), 12% (liver), and 19% (abdomen and pelvis) and for ICRP 103 by -34% (head), 37% (chest), 74% (coronary artery), 16% (liver), and 12% (abdomen and pelvis). All results were energy independent.
Conclusion: These differences in estimates of effective dose suggest the need to reassess DLP to E conversion coefficients when adopting ICRP 103, particularly for scans over the breast. For the evaluated scanner, DLP to E conversion coefficients were energy independent, but ICRP 60-based conversion coefficients underestimated effective dose relative to organ dose-based calculations.